Keyphrases
Kaposi's Sarcoma-associated Herpesvirus
100%
Kshv
54%
Virus
38%
Infected Cells
36%
Latency
20%
Lytic Reactivation
19%
Viral Genome
18%
Epidemic Mitigation
18%
3-axis
18%
LAMP2
18%
Lytic Replication
18%
Portal Vertex
18%
Activating Transcription Factor 4 (ATF4)
18%
ORF45
18%
Superinfection
18%
Lockdown
18%
Cas9 Protein
18%
Viral Disease
18%
Latently Infected Cells
18%
Nuclear Pore
18%
Capsid
18%
Ribosomal RNA
18%
Subnuclear Localization
18%
Nucleolar
18%
Nuclear Speckles
18%
Emerging Viruses
18%
Pandemic Outbreak
18%
RNA-binding Protein
18%
Latent Infection
16%
Ribosomal RNA Transcription
10%
Nucleolar Protein
10%
Herpesvirus
10%
Herpesvirus Infection
9%
Latency Establishment
9%
Coronavirus Family
9%
Human Coronavirus (HCoV)
9%
Livestock
9%
Biological Properties
9%
Coronavirus
9%
Cross-species Transmission
9%
SARS-CoV-2 Pandemic
9%
Viral Infection
7%
Viral Proteins
7%
Lytic Cycle
6%
Socio-economic Impact
6%
Quarantine Strategy
6%
SARS-CoV-2 Disease
6%
Epidemic Outbreak
6%
Infected Individual
6%
Pharmaceutical Intervention
6%
Immunology and Microbiology
Human Herpesvirus 8
95%
Viral Disease
31%
CRISPR/Cas9
18%
LANA
18%
Dendritic Cell Lysosome Associated Membrane Protein
18%
Capsid
18%
Protein RNA Binding
18%
Upregulation
18%
Protein Binding
18%
Superinfection
18%
Nuclear Pore
18%
Emerging Viruses
18%
Virus Genome
17%
Lytic Cycle
13%
Maturation
13%
RNA Transcription
13%
Host Cell
9%
Coronavirus
9%
Immunofluorescence
9%
Coronavirinae
9%
Coronaviridae
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Gene Expression
7%
Wild Type
5%
Herpesviridae
5%
Mediator
5%
Biochemistry, Genetics and Molecular Biology
Human Herpesvirus 8
71%
Capsid
18%
Ribosomal RNA
18%
RNA-binding Protein
18%
RNA
18%
CRISPR/Cas9
18%
Upregulation
18%
Nuclear Pore
18%
ATF4
18%
Lysosome
18%
Membrane Protein
18%
Splicing Factor
12%
Maturation
8%
Virus Genome
8%
RNA Transcription
6%
PABPN1
6%
Poly(A)-Binding Protein
6%
Wild Type
5%
Herpesviridae
5%
Mediator
5%
